Introduction Bitcoin faces a difficult near-term path as macro uncertainty and a lack of decisive catalysts temper upside momentum. Market odds suggest the digitalIntroduction Bitcoin faces a difficult near-term path as macro uncertainty and a lack of decisive catalysts temper upside momentum. Market odds suggest the digital

Prediction Markets: Bitcoin Won’t Reach $100K Before June

5 min read
Prediction Markets: Bitcoin Won't Reach $100k Before June

Introduction
Bitcoin faces a difficult near-term path as macro uncertainty and a lack of decisive catalysts temper upside momentum. Market odds suggest the digital asset may remain below the $100,000 level through the first half of 2026, even as long-term holders and institutional players weigh strategic bets. A confluence of prediction-market signals and on-chain indicators paints a cautious picture for BTC, with traders eyeing potential volatility later in the year but increasingly expecting a protracted period of consolidation.

Key Takeaways

  • BTC price has a less than 10% chance of retaking $100,000 before Feb. 1.
  • Traders predict that Bitcoin is unlikely to see $100,000 before June.
  • Bitcoin’s price will likely drop below Strategy’s cost basis.
  • Market expectations for macro catalysts remain sparse, keeping BTC in a rangebound regime for now.

Tickers mentioned: $BTC, MicroStrategy (NASDAQ: MSTR)

Sentiment: Bearish

Price impact: Negative. The narrative points to ongoing downside risk and extended a consolidative phase, potentially delaying a return to six-figure levels.

Trading idea (Not Financial Advice): Hold. With clear near-term headwinds and mixed catalysts, a cautious stance is prudent until price action offers clearer direction.

Market context: The broader crypto market is navigating a risk-off stance amid macro uncertainty, with investors awaiting policy signals and liquidity conditions before committing to a decisive BTC breakout.

Less than 10% chance BTC hits $100,000 before February

The consensus among retail and professional traders on prediction platforms remains subdued for a quick resumption of a six-figure BTC. As of Jan. 22, Polymarket bettors assign roughly 6% odds to BTC surpassing $100,000 before Jan. 31, while Kalshi places about a 7% odds on BTC testing the $100,000 level before the end of January.

Bitcoin’s intramonth momentum has been modest. The year-to-date high for 2026 sits near $97,900, reached mid-January, with BTC/USD last trading above $100,000 in mid-November. If a pattern similar to prior drawdowns plays out, BTC could reclaim $100,000 in a matter of weeks if risk-on liquidity returns, but the current setup suggests a longer road to a sustained breakout.

The market narrative remains cautious, supported by fresh technical readings and macro constraints. A trend of pauses and retracements underpins the view that a rapid ascent back to six figures is unlikely in the near term.

The outlook diverges somewhat on longer horizons. Kalshi projects a 65% probability that BTC breaks $100,000 before June 2026, reflecting the possibility of a delayed but eventual upside if macro conditions improve or if new on-chain demand surges. In the nearer term, traders on Polymarket still see a substantial risk of consolidation below $100,000 through February, with a notable probability of renewed volatility later in the year depending on external catalysts.

Market watchers also note the possibility of a dip toward lower levels before any meaningful rebound. Polymarket data point to a 65% likelihood of BTC slipping toward $80,000 first, before rebounding to the $100,000 threshold later in 2026. And sentiment across several platforms remains tilted toward downside risk, with $70,000–$75,000 cited as plausible mid-year baselines if demand remains tepid.

Will BTC price drop below Strategy’s cost basis?

There are mounting signs that Bitcoin has entered a bear-market phase, with several price targets calling for drawdowns into the $58,000 territory in the not-too-distant future. On prediction markets, traders assign a 75% probability that BTC trades below what some analysts regard as a cost basis around $75,979 in 2026. That level is a rough average of prior entry points for market participants who accumulate in circumscribed windows during downturns.

Despite the looming downside, institutional demand remains a talking point. Polymarket’s odds for Strategy selling Bitcoin in 2026 sit below 26%, suggesting a low probability of forced liquidations or large-scale deleveraging by major holders in the near term. Yet expectations for routine, ongoing accumulation persist, underscoring a bifurcated view: risk-off attitudes among many traders, combined with steady, patient accumulation by strategic hodlers.

MicroStrategy’s activity continues to attract attention as a bellwether for corporate BTC reserves. The company recently expanded its Bitcoin treasury to well over 700,000 BTC after purchasing thousands of coins for roughly $2.13 billion. The prospect of MicroStrategy (NASDAQ: MSTR) maintaining a significant, long-duration stake remains a key variable in the market’s balance of fear and conviction. Market observers continue to monitor whether the firm will push toward larger targets such as 800,000 BTC by year-end 2026, or adjust its holdings in response to evolving price dynamics.

In sum, the near-term path for Bitcoin appears punctuated by resistance at the $100,000 mark, with a broad spectrum of probabilities smoothed into a central expectation of continued caution. While a handful of traders anticipate a later-year rally, the prevailing tone emphasizes discipline, risk management, and a wait-and-see approach as macro conditions unfold.

This article was originally published as Prediction Markets: Bitcoin Won’t Reach $100K Before June on Crypto Breaking News – your trusted source for crypto news, Bitcoin news, and blockchain updates.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29